Introduction: Multiple myeloma is a hematologic disease that is progressive and incurable characterized by irregular and clonal multiplication plasmacytes in the bone marrow. The main clinical manifestations caused by the presence of neoplastic cells in the bone tissue, and excessive production of immunoglobulins and humoral immune suppression normal. Daratumumab is an anti-CD38 monoclonal antibody that promise results in managing the disease multiple myeloma.

Objective: This study aimed to determine the scientific evidence regarding the impact of cytomegalovirus infection in treatment programs daratumumab in multiple myeloma patients extensively pre-treatment.

Methods: For this purpose, an integrative literature review conducted on a different database, which consists of a period of 5 years.

Results: The study analysis revealed that the reactivation of cytomegalovirus infection may occur during the use of daratumumab in previously treated multiple myeloma patients, which led to discontinuation of treatment, compromised drug efficacy and disease progression favored. In addition, it was observed that even with prophylactic antiviral therapy there is a reactivation of infection in some cases, and death, in a more serious situation.

Conclusion: So, even considering some of the reports on these topics is available in the scientific literature, this review suggests that cytomegalovirus reactivation can interfere daratumumab therapy, especially in heavily pretreated multiple myeloma patients. In addition, this research can contribute as a tool for clinical decisions and management of adverse events in medical practice, demonstrating the importance of monitoring patients for the possibility of cytomegalovirus reactivation in patients with heavily pretreated myeloma.

Comparison of different cytomegalovirus disease following haploidentical hematopoietic stem cell transplantation

Cytomegalovirus (CMV) can cause end-organ disease including pneumonia, gastroenteritis, retinitis, and encephalitis in hematopoietic stem cell transplant recipients. the potential difference between the different CMV disease remains uncertain.

This study aimed to compare the clinical characteristics, risk factors, and mortality among the different CMV disease. A retrospective case-control study carried out based on a cohort of 3862 patients undergoing haploidentical hematopoietic stem cell transplantation in a single-center. CMV disease occurred in 113 (2.92%) of 3,862 haplo-HSCT recipients, including the possibility of CMV pneumonia (CMVP, n = 34), proved to CMV gastroenteritis (CMVG, n = 34), CMV retinitis (CMVR, n = 31) , the possibility of CMV encephalitis (CMVE, n = 7), and disseminated CMV disease (Di-CMVD, n = 7). Most (91.2%) cases CMVG developed in 100 days, while the majority (90.3%) cases of late-onset CMVR.

Lenti-hTERT virus
G200	ABM	10 ml	EUR 811

Lenti-Bmi1 Virus
LV610	ABM	10 ml	EUR 811

Lenti-CDK4 Virus
LV611	ABM	10 ml	EUR 811

AAV2-Luc Control Virus
AAV-320	Cell Biolabs	50 ?L	EUR 1018
Description: Luciferase control virus of AAV serotype 2.

AAV1-Luc Control Virus
AAV-321	Cell Biolabs	50 ?L	EUR 1018
Description: Luciferase control virus of AAV serotype 1.

AAV3-Luc Control Virus
AAV-323	Cell Biolabs	50 ?L	EUR 1018
Description: Luciferase control virus of AAV serotype 3.

AAV4-Luc Control Virus
AAV-324	Cell Biolabs	50 ?L	EUR 1018
Description: Luciferase control virus of AAV serotype 4.

AAV5-Luc Control Virus
AAV-325	Cell Biolabs	50 ?L	EUR 1018
Description: Luciferase control virus of AAV serotype 5.

AAV6-Luc Control Virus
AAV-326	Cell Biolabs	50 ?L	EUR 1018
Description: Luciferase control virus of AAV serotype 6.

Rev-A3R5-GFP/Luc HIV Reporter Cells
HRC-2	101Bio	-	Ask for price

Rev-CEM-GFP/Luc HIV Reporter Cells
HRC-5	101Bio	-	Ask for price

Lenti-hTERT Antisense virus
G201	ABM	10 ml	EUR 735

Lenti-hTERT-Neo Virus
G204	ABM	10 ml	EUR 811

Lenti-Myc T58A Virus
G217	ABM	10 ml	EUR 811

Lenti-p53 siRNA Virus
G219	ABM	10 ml	EUR 811

Lenti-Ras V12 Virus
G221	ABM	10 ml	EUR 811

Lenti-Rb siRNA Virus
G223	ABM	10 ml	EUR 811

Steady-Luc Firefly HTS Assay Kit (10x100 ml)
30028-3	Biotium	1KIT	EUR 3145
Description: Minimum order quantity: 1 unit of 1KIT

A2ld1 3'UTR Luciferase Stable Cell Line
TU101049	ABM	1.0 ml	Ask for price

A2ld1 3'UTR GFP Stable Cell Line
TU250006	ABM	1.0 ml	Ask for price

A2ld1 3'UTR Luciferase Stable Cell Line
TU200006	ABM	1.0 ml	Ask for price

A2LD1 3'UTR GFP Stable Cell Line
TU050004	ABM	1.0 ml	EUR 1394

A2ld1 3'UTR GFP Stable Cell Line
TU151049	ABM	1.0 ml	Ask for price

A2LD1 3'UTR Luciferase Stable Cell Line
TU000004	ABM	1.0 ml	EUR 1394

Mouse Actc Differentiation Reporter (pGreenZeo, Virus)
SR10010VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human Tnnt2 Differentiation Reporter (pGreenZeo, Virus)
SR10012VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse Tnnt2 Differentiation Reporter (pGreenZeo, Virus)
SR10013VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse SM22a Differentiation Reporter (pGreenZeo, Virus)
SR10014VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human GFAP Differentiation Reporter (pGreenZeo, Virus)
SR10015VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse GFAP Differentiation Reporter (pGreenZeo, Virus)
SR10016VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human CD11b Differentiation Reporter (pGreenZeo, Virus)
SR10017VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse EMR1 Differentiation Reporter (pGreenZeo, Virus)
SR10018VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse Col2a1 Differentiation Reporter (pGreenZeo, Virus)
SR1001VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse CD44 Differentiation Reporter (pGreenZeo, Virus)
SR10020VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human BM88 Differentiation Reporter (pGreenZeo, Virus)
SR10021VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse Camk2a Differentiation Reporter (pGreenZeo, Virus)
SR10022VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse GAD67 Differentiation Reporter (pGreenZeo, Virus)
SR10023VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Rat NSE Differentiation Reporter (pGreenZeo, Virus)
SR10024VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse MBP Differentiation Reporter (pGreenZeo, Virus)
SR10026VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human Opsin Differentiation Reporter (pGreenZeo, Virus)
SR10027VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human Insulin Differentiation Reporter (pGreenZeo, Virus)
SR10028VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human LCK Differentiation Reporter (pGreenZeo, Virus)
SR10032VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Rat Nestin Differentiation Reporter (pGreenZeo, Virus)
SR10034VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human Nestin Differentiation Reporter (pGreenZeo, Virus)
SR10035VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse ALBP Differentiation Reporter (pGreenZeo, Virus)
SR10036VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human NGN3 Differentiation Reporter (pGreenZeo, Virus)
SR10037VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human PDX1 Differentiation Reporter (pGreenZeo, Virus)
SR10039VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human Osteocalcin Differentiation Reporter (pGreenZeo, Virus)
SR1003VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse PDX1 Differentiation Reporter (pGreenZeo, Virus)
SR10040VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human MAP2 Differentiation Reporter (pGreenZeo, Virus)
SR10047VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human FABP7 Differentiation Reporter (pGreenZeo, Virus)
SR10048VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human ACTC Differentiation Reporter (pGreenZeo, Virus)
SR10049VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human B29 Differentiation Reporter (pGreenZeo, Virus)
SR1004VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse Myogenin Differentiation Reporter (pGreenZeo, Virus)
SR10050VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human GFAP Differentiation Reporter (pRedZeo, Virus)
SR10051VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse B29 Differentiation Reporter (pGreenZeo, Virus)
SR1005VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human NKX2.5 Differentiation Reporter (pGreenZeo, virus)
SR10067VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse CD8 Differentiation Reporter (pGreenZeo, Virus)
SR1006VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse CD68 Differentiation Reporter (pGreenZeo, Virus)
SR1008VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human CD2 Differentiation Reporter (pGreenZeo, Virus)
SR1009VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Oct4 CR4-pGreenFire Response Reporter (virus)
SR20070-VA-1	SBI	>2 x 10^6 IFUs	EUR 735

A2ld1/ Rat A2ld1 ELISA Kit
ELI-24687r	Lifescience Market	96 Tests	EUR 886

Lenti-EF1α-hTERT Virus
G706	ABM	10 ml	EUR 912

Lenti-Bmi1 Virus, High Titer
LV608	ABM	5 x 20 ul	EUR 1521

Lenti-CDK4 Virus, High Titer
LV609	ABM	5 x 20 ul	EUR 1521

Lenti-hTERT Virus, High Titer
LV615	ABM	5 x 20 ul	EUR 1521

NF-kB/293/GFP-Luc Transcriptional Reporter Cell Line
TR860A-1	SBI	>2 x 10^6 cells	EUR 3263

A2LD1 Antibody
39425-100ul	SAB	100ul	EUR 390

A2LD1 Antibody
39426-100ul	SAB	100ul	EUR 390

Human MLC-2v Differentiation Reporter (pGreenZeo, Virus)
SR10011VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human GFAP Differentiation Reporter (pGreenZeo, Virus) Puro
SR10015VA-P	SBI	>2 x 10^6 IFUs	EUR 755

Mouse IBA-1 Differentiation Reporter (pGreenZeo, Virus)
SR10019VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Mouse Alpha-Tubulin Differentiation Reporter (pGreenZeo, Virus)
SR10025VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human SPP-1 Differentiation Reporter (pGreenZeo, Virus)
SR1002VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human Keratin 14 Differentiation Reporter (pGreenZeo, Virus)
SR10038VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human Doublecortin (DCX) Differentiation Reporter (pGreenZeo, Virus)
SR10041VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Human HLA-DRa Differentiation Reporter (pGreenZeo, Virus)
SR1007VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Lenti-HPV-16 E6/E7 Virus
G268	ABM	10 ml	EUR 735

Lenti-EF1α-hTERT-Hygro Virus
LV631	ABM	10 ml	EUR 1059

Lenti-hTERT-Neo Virus, High Titer
LV622	ABM	5 x 20 ul	EUR 1521

Lenti-Myc T58A Virus, High Titer
LV618	ABM	5 x 20 ul	EUR 1521

Lenti-p53 siRNA Virus, High Titer
LV619	ABM	5 x 20 ul	EUR 1521

Lenti-Ras V12 Virus, High Titer
LV620	ABM	5 x 20 ul	EUR 1521

Lenti-Rb siRNA Virus, High Titer
LV621	ABM	5 x 20 ul	EUR 1521

Human E-Cadherin, CDH1 Differentiation Reporter (pGreenZeo, virus)
SR10070VA-1	SBI	>2 x 10^6 IFUs	EUR 755

Sox2 SRR2-pGreenFire Response Reporter, pre-packaged virus
SR20071-VA-1	SBI	>2 x 10^6 IFUs	EUR 735

A2LD1 cloning plasmid
CSB-CL883610HU-10ug	Cusabio	10ug	EUR 238
Description: A cloning plasmid for the A2LD1 gene.

anti- A2LD1 antibody
FNab00013	FN Test	100µg	EUR 548.75
Description: Antibody raised against A2LD1

Anti-A2LD1 antibody
PAab00013	Lifescience Market	100 ug	EUR 386

Lenti-CMV-hTERT-RFP-2A-Puro Virus
LV625	ABM	10 ml	EUR 1059

Lenti-CMV-hTERT-GFP-2A-Puro Virus
LV623	ABM	10 ml	EUR 1059

Lenti-EF1α-hTERT Virus, High Titer
LV616	ABM	5 x 20 ul	EUR 1724

pMIR-Reporter-RASA1(3
PVTB00444-2a	Lifescience Market	2 ug	EUR 356

pMIR-Reporter-IL13(3
PVTB00445-2a	Lifescience Market	2 ug	EUR 356

Human Alpha-Actin 2, ACTA2 Differentiation Reporter (pGreenZeo, virus)
SR10068VA-1	SBI	>2 x 10^6 IFUs	EUR 755

pLL-CMV-GFP-T2A-Puro [Lenti-LabelerTM virus]
LL100VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-CMV-GFP-T2A-Blast [Lenti-LabelerTM virus]
LL105VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-CMV-RFP-T2A-Puro [Lenti-LabelerTM virus]
LL110VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-CMV-RFP-T2A-Blast [Lenti-LabelerTM virus]
LL115VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-CMV-BFP-T2A-Puro [Lenti-LabelerTM virus]
LL120VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-CMV-BFP-T2A-Blast [Lenti-LabelerTM virus]
LL125VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-CMV-Luciferase-T2A-Puro [Lenti-LabelerTM virus]
LL150VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-EF1a-GFP-T2A-Puro [Lenti-LabelerTM virus]
LL200VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-EF1a-GFP-T2A-Blast [Lenti-LabelerTM virus]
LL205VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-EF1a-RFP-T2A-Puro [Lenti-LabelerTM virus]
LL210VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-EF1a-RFP-T2A-Blast [Lenti-LabelerTM virus]
LL215VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-EF1a-BFP-T2A-Puro [Lenti-LabelerTM virus]
LL220VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-EF1a-BFP-T2A-Blast [Lenti-LabelerTM virus]
LL225VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-EF1a-Luciferase-T2A-Puro [Lenti-LabelerTM virus]
LL250VA-1	SBI	>2x10^6 IFUs	EUR 675

pLL-CMV-rFLuc-T2A-GFP [Lenti-LabelerTM virus]
LL300VA-1	SBI	>2x10^6 IFUs	EUR 697

Lenti-HPV-16 E6/E7 Virus, High Titer
LV617	ABM	5 x 20 ul	EUR 1420

A2LD1 ELISA KIT|Human
EF007512	Lifescience Market	96 Tests	EUR 689

A2LD1 protein (His tag)
80R-1717	Fitzgerald	50 ug	EUR 397
Description: Purified recombinant Human A2LD1 protein

A2LD1 Recombinant Protein (Mouse)
RP112952	ABM	100 ug	Ask for price

A2LD1 Recombinant Protein (Rat)
RP188432	ABM	100 ug	Ask for price

A2LD1 Recombinant Protein (Human)
RP000007	ABM	100 ug	Ask for price

A2LD1 sgRNA CRISPR Lentivector (Human) (Target 3)
K0013604	ABM	1.0 ug DNA	EUR 154

A2ld1 sgRNA CRISPR Lentivector (Rat) (Target 3)
K7213404	ABM	1.0 ug DNA	EUR 154

A2ld1 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K4697504	ABM	1.0 ug DNA	EUR 154

Lentiviral Dual Reporter: CMV-GFP-T2A-Luciferase pre-packaged virus
BLIV101VA-1	SBI	>2 x10^6 IFUs	EUR 803

Lentiviral Triple Reporter: CMV-Luciferase-RFP-TK pre-packaged virus
BLIV102VA-1	SBI	>2 x10^6 IFUs	EUR 803

Lentiviral Dual Reporter: UBC-RFP-T2A-Luciferase pre-packaged virus
BLIV200VA-1	SBI	>2 x10^6 IFUs	EUR 803

Lentiviral Triple Reporter: UBC-Luciferase-RFP-TK pre-packaged virus
BLIV202VA-1	SBI	>2 x10^6 IFUs	EUR 803

Lentiviral Triple Reporter: MSCV-Luciferase-RFP-TK pre-packaged virus
BLIV302VA-1	SBI	>2 x10^6 IFUs	EUR 803

BLIV 2.0 Reporter: CMV-Luciferase-EF1a-copGFP Pre-packaged Virus
BLIV511VA-1	SBI	>2 x10^6 IFUs	EUR 803

Human MLC-2v Differentiation Reporter (pGreenZeo, Virus), EF1-Neo Marker
SR10011VA-N	SBI	>2 x 10^6 IFUs	EUR 755

pGL3 3'UTR reporter WT 1.3 kb CD274 Hs 3'UTR Final Plasmid
PVT17094	Lifescience Market	2 ug	EUR 325

SKOV-3/Luc Cell Line
AKR-232	Cell Biolabs	1 vial	EUR 572
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line.

pMR-Luc
PVT14074	Lifescience Market	2 ug	EUR 703

pT7- Luc
PVT10670	Lifescience Market	2 ug	EUR 301

pSBE- Luc
PVT10816	Lifescience Market	2 ug	EUR 301

pTRE3G- LUC
PVT10818	Lifescience Market	2 ug	EUR 301

pAP1- Luc
PVT10819	Lifescience Market	2 ug	EUR 301

pHSE- Luc
PVT10820	Lifescience Market	2 ug	EUR 266

pGRE- luc
PVT10821	Lifescience Market	2 ug	EUR 266

pCRE- Luc
PVT10825	Lifescience Market	2 ug	EUR 301

pViperin- Luc
PVT10826	Lifescience Market	2 ug	EUR 301

pTA- Luc
PVT10827	Lifescience Market	2 ug	EUR 301

pTAL- Luc
PVT10829	Lifescience Market	2 ug	EUR 301

pIRF3- Luc
PVT10830	Lifescience Market	2 ug	EUR 301

p53- Luc
PVT10836	Lifescience Market	2 ug	EUR 266

pBV-Luc
PVT12245	Lifescience Market	2 ug	EUR 703

Pooled Virus Library of all Lenti-miR microRNA Precursor Constructs [4 virus aliquots]
PMIRHPLVA-1	SBI	4 virus aliquots	EUR 4979

Lenti-CMV-hTERT-RFP-2A-Puro Virus, High Titer
LV626	ABM	5 x 20 ul	EUR 1826

Lenti-EF1?¡À-hTERT-Hygro Virus, High Titer
LV632	ABM	5 x 20 ul	EUR 1826

Lenti-CMV-hTERT-GFP-2A-Puro Virus, High Titer
LV624	ABM	5 x 20 ul	EUR 1826

Sox2 SRR2-pGreenFire Response Reporter (pre-packaged virus, EF1-Puro marker)
SR20071-VA-P	SBI	>2 x 10^6 IFUs	EUR 735

A2LD1 ORF Vector (Human) (pORF)
ORF000003	ABM	1.0 ug DNA	EUR 95

A2ld1 ORF Vector (Mouse) (pORF)
ORF037652	ABM	1.0 ug DNA	EUR 506

A2ld1 ORF Vector (Rat) (pORF)
ORF062812	ABM	1.0 ug DNA	EUR 506

2C::tdTomato Reporter
PVT10473	Lifescience Market	2 ug	EUR 266

pMIR- Reporter Plasmid
PVT1324	Lifescience Market	2 ug	EUR 266

A549 / Luciferase (Puromycin) stable cell line
SC043-Luc	GenTarget	2 x 106 cell/ml x 1ml	EUR 920
Description: Luciferase (firefry) expression stable cell line in A549 human cancer cell line with Puromycin marker.

Human AsPC1 / Luciferase Cell Line
SC062-Luc	GenTarget	2 x 106 cell/ml x 1ml	EUR 1500
Description: Firefly luciferase expression stable cell line in Human AsPC1 cells with Puromycin resistance

mouse MOPC315 / Luciferase Cell Line
SC063-Luc	GenTarget	2 x 106 cell/ml x 1ml	EUR 2225
Description: Firefly luciferase expression stable cell line in mouse MOPC315 cells with Puromycin resistance

Huamn SW403 / Luciferase Stable Cells
SC067-Luc	GenTarget	2 x 106 cell/ml x 1ml	EUR 1500
Description: Firefly luciferase expression stable cell line in human SW403 cells with Puromycin resistance

Human PANC-1 / Luciferase (Puro) Cell Line
SC068-Luc	GenTarget	2 x 106 cell/ml x 1ml	EUR 2225
Description: Firefly luciferase expression stable cell line in Human PANC-1 cells with Puromycin resistance

β-Lactamase (Luciferase) lentiviral particles
LVP335-luc	GenTarget	1x107 IFU/ml x 200ul	EUR 349
Description: pre-made lentiviral particles expressing β-Lactamase gene. A firefly luciferase marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

pLL-CMV-rFLuc-T2A-GFP-mPGK-Puro [Lenti-LabelerTM virus]
LL310VA-1	SBI	>2x10^6 IFUs	EUR 697

pLL-CMV-rFLuc-T2A-mRFP-mPGK-Puro [Lenti-LabelerTM virus]
LL320VA-1	SBI	>2x10^6 IFUs	EUR 697

pLL-EF1a-rFLuc-T2A-GFP-mPGK-Puro [Lenti-LabelerTM virus]
LL410VA-1	SBI	>2x10^6 IFUs	EUR 697

pLL-EF1a-rFLuc-T2A-mRFP-mPGK-Puro [Lenti-LabelerTM virus]
LL420VA-1	SBI	>2x10^6 IFUs	EUR 697

Virus Parainfluenza Virus 3 (HPIV-3) Protein
abx670267-1ml	Abbexa	1 ml	EUR 592

BLIV 2.0 Reporter: MSCV-Luciferase-EF1a-copGFP-T2A-Puro Pre-packaged Virus
BLIV713VA-1	SBI	>2 x10^6 IFUs	EUR 803

pGreenFire 2.0 NFAT reporter virus (pGF2-NFAT-rFluc-T2A-GFP-mPGK-Puro)
TR451VA-P	SBI	>2 x 10^6 IFUs	EUR 767

p21-Luc Plasmid
PVTB00035-2c	Lifescience Market	2 ug	EUR 356

pGL3-ELAM-Luc
PVT14533	Lifescience Market	2 ug	EUR 599

proE-cad178-Luc
PVT14614	Lifescience Market	2 ug	EUR 599

pSynSRE-T-Luc
PVT14626	Lifescience Market	2 ug	EUR 703

pUC57-Tac-Luc
PVT18215	Lifescience Market	2 ug	EUR 258

IgK- IFN- luc
PVT10425	Lifescience Market	2 ug	EUR 266

pNFAT- TA- Luc
PVT10808	Lifescience Market	2 ug	EUR 266

pE2F- TA- Luc
PVT10809	Lifescience Market	2 ug	EUR 266

pISRE- TA- Luc
PVT10810	Lifescience Market	2 ug	EUR 266

pGAS- TA- Luc
PVT10811	Lifescience Market	2 ug	EUR 266

pP53- TA- luc
PVT10814	Lifescience Market	2 ug	EUR 301

pStat3- TA- luc
PVT10815	Lifescience Market	2 ug	EUR 301

pHes1 (2.5k)- Luc
PVT10832	Lifescience Market	2 ug	EUR 266

pHes1 (467)- luc
PVT10833	Lifescience Market	2 ug	EUR 266

pNF-kB-Luc
PVT1322	Lifescience Market	2 ug	EUR 325

Human Gamma- glutamylaminecyclotransferase, A2LD1 ELISA KIT
ELI-24712h	Lifescience Market	96 Tests	EUR 824

Mouse Gamma- glutamylaminecyclotransferase, A2ld1 ELISA KIT
ELI-24713m	Lifescience Market	96 Tests	EUR 865

Bovine Gamma- glutamylaminecyclotransferase, A2LD1 ELISA KIT
ELI-49723b	Lifescience Market	96 Tests	EUR 928

A2LD1 sgRNA CRISPR Lentivector set (Human)
K0013601	ABM	3 x 1.0 ug	EUR 339

A2ld1 sgRNA CRISPR Lentivector set (Rat)
K7213401	ABM	3 x 1.0 ug	EUR 339

A2ld1 sgRNA CRISPR Lentivector set (Mouse)
K4697501	ABM	3 x 1.0 ug	EUR 339

pGreenFire 2.0 NFkB reporter virus (pGF2-NF?B-rFluc-T2A-GFP-mPGK-Puro)
TR412VA-P	SBI	>2 x 10^6 IFUs	EUR 767

pGreenFire 2.0 HIF-1 reporter virus (pGF2-HIF1-rFluc-T2A-GFP-mPGK-Puro)
TR426VA-P	SBI	>2 x 10^6 IFUs	EUR 767

pGreenFire 2.0 AP-1 reporter virus (pGF2-AP1-rFluc-T2A-GFP-mPGK-Puro)
TR452VA-P	SBI	>2 x 10^6 IFUs	EUR 767

Luciferase Reporter Assay Kit
K2181-200	ApexBio	200 assays	EUR 181

Fire-resistant CMV infection and CMV viral load at different levels associated with an increased risk of CMVP, CMVG, and CMVR. Compared with patients without CMV disease, significantly higher non-relapse mortality at 1 year after transplantation was observed in patients with CMVP and CMVR not CMVG. Patients with CMVP, In-CMVD, and CMVE have an overall mortality rate higher after diagnosis than patients with CMVG and CMVR (61.7%, 57.1%, 40.0% vs 27.7%, 18.6% , P = 0.001). In conclusion, time of onset, the viral dynamics, and different mortality between different CMV disease. CMV disease mortality remains high, especially for the CMVP, In-CMVD, and CMVE.